Skip to Content
MilliporeSigma

79622

Sigma-Aldrich

Phosphoric acid

greener alternative

puriss. p.a., crystallized, ≥99.0% (T)

Synonym(s):

Orthophosphoric acid

Sign Into View Organizational & Contract Pricing

Select a Size

About This Item

Linear Formula:
H3PO4
CAS Number:
7664-38-2
Molecular Weight:
98.00
Beilstein/REAXYS Number:
1921286
EC Number:
231-633-2
MDL number:
MFCD00011340
UNSPSC Code:
12352106
PubChem Substance ID:
329768533
NACRES:
NA.21

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

vapor density

3.4 (vs air)

Quality Level

200

vapor pressure

2.2 mmHg ( 20 °C)
5 mmHg ( 25 °C)

grade

puriss. p.a.

assay

≥99.0% (T)

form

powder or crystals

quality

crystallized

greener alternative product characteristics

Design for Energy Efficiency
Learn more about the Principles of Green Chemistry.

sustainability

Greener Alternative Product

impurities

≤0.002% KMnO4-reducing matter (as O)

bp

158 °C (lit.)

mp

~40 °C (lit.)
~40 °C

solubility

water: 850 g/L at 20 °C

density

1.685 g/mL at 25 °C (lit.)

anion traces

chloride (Cl-): ≤5 mg/kg
nitrate (NO3-): ≤5 mg/kg
phosphite, hypophosphite (as H3PO3): ≤500 mg/kg
sulfate (SO42-): ≤30 mg/kg

cation traces

As: ≤1 mg/kg
Ca: ≤10 mg/kg
Cd: ≤1 mg/kg
Co: ≤1 mg/kg
Cr: ≤1 mg/kg
Cu: ≤1 mg/kg
Fe: ≤10 mg/kg
K: ≤5 mg/kg
Mg: ≤1 mg/kg
Mn: ≤1 mg/kg
Na: ≤50 mg/kg
Ni: ≤1 mg/kg
Pb: ≤1 mg/kg
Zn: ≤1 mg/kg

greener alternative category

Enabling

SMILES string

OP(O)(O)=O

InChI

1S/H3O4P/c1-5(2,3)4/h(H3,1,2,3,4)

InChI key

NBIIXXVUZAFLBC-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

Phosphoric acid (H3PO4) is also known as orthophosphoric acid. It serves as an intermediary or reagent in various manufacturing processes.
The product is crystalline phosphoric acid.
We are committed to bringing you Greener Alternative Products, which belong to one of the four categories of greener alternatives. Phosphoric acid-doped polybenzimidazole (PBI) membranes offer a cleaner path to energy by enabling high-temperature fuel cells that efficiently convert hydrogen into electricity with low emissions. Their durability and proton conductivity make them ideal for sustainable power systems. Click here for more information.

Application

Phosphoric acid has been employed as an oxidation reagent in a study.1 It may be used in the preparation of ammonium phosphate.
Phosphoric acid is used:
  • As a catalyst in the nucleophilic addition to imines.
  • In the synthesis of porous phosphoric acid-based geopolymers.
  • In the synthesis of mono-alkyl phosphates from simple aliphatic alcohols in the presence of acetic anhydride activator.

Other Notes

Concentrated phosphoric acid is approx. 85% H3PO4 (aqueous).

Disclaimer

product may become solid, becomes liquid on heating to 50°C

pictograms

CorrosionExclamation mark
GHS05,GHS07

signalword

Danger

Hazard Classifications

Acute Tox. 4 Oral - Eye Dam. 1 - Met. Corr. 1 - Skin Corr. 1B

Storage Class

8A - Combustible corrosive hazardous materials

wgk_germany

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
BCCG7861
BCCF1131
BCCF0685
0000105107
0000103547

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Christian Reichel et al.
Drug testing and analysis, 9(11-12), 1721-1730 (2017-09-21)
Luspatercept (ACE-536, ACVR2B-Fc), a fusion protein consisting of the extracellular domain of ActRIIB receptor and the Fc-part of human immunoglobulin G1 (IgG1), is currently under clinical development (Phase III). It stimulates the formation of red blood cells and hence may
Eagleson M.
Concise Encyclopedia Chemistry, 67-67 (1994)
Alessio Ciulli et al.
Journal of medicinal chemistry, 49(16), 4992-5000 (2006-08-04)
Mapping interactions at protein-ligand binding sites is an important aspect of understanding many biological reactions and a key part of drug design. In this paper, we have used a fragment-based approach to probe "hot spots" at the cofactor-binding site of
Alex W Gregory et al.
Organic letters, 15(17), 4330-4333 (2013-08-30)
A highly enantioselective hydroamination/N-sulfonyliminium cyclization cascade is reported using a combination of gold(I) and chiral phosphoric acid catalysts. An initial 5-exo-dig hydroamination and a subsequent phosphoric acid catalyzed cyclization process provide access to complex sulfonamide scaffolds in excellent yield and
W M Fennis et al.
Journal of dental research, 93(1), 36-41 (2013-10-25)
The objective of this randomized control trial was to compare the five-year clinical performance of direct and indirect resin composite restorations replacing cusps. In 157 patients, 176 restorations were made to restore maxillary premolars with Class II cavities and one
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service